Barnhart J W, Li D L, Cheng W D
Department of Pharmacology, Merrell Dow Research Institute, Indianapolis, Indiana 46268.
Am J Cardiol. 1988 Jul 25;62(3):52B-56B. doi: 10.1016/s0002-9149(88)80052-3.
Probucol has been investigated extensively in vivo and ex vivo. However, little information is available on direct treatment of cultured cells. Treatment of cultured hepatocytes by 1 to 10 microM probucol for 16 to 20 hours had no apparent deleterious effect on the cell, and in fact decreased lactic dehydrogenase leakage. Also, total cellular cholesterol was increased, cholesterol synthesis was decreased, and cholesterol esterification was increased. The increase in cellular cholesterol was not the result of increased lipoprotein uptake but appeared to be the result of an interaction between cell and lipoprotein in which the cell became enriched and the lipoprotein depleted in cholesterol. This type of change in lipoprotein composition after treatment is also observed clinically.
普罗布考已在体内和体外进行了广泛研究。然而,关于其对培养细胞的直接处理的信息却很少。用1至10微摩尔的普罗布考处理培养的肝细胞16至20小时,对细胞没有明显的有害影响,事实上还减少了乳酸脱氢酶的泄漏。此外,细胞总胆固醇增加,胆固醇合成减少,胆固醇酯化增加。细胞胆固醇的增加不是脂蛋白摄取增加的结果,而是细胞与脂蛋白之间相互作用的结果,其中细胞胆固醇富集而脂蛋白胆固醇耗竭。治疗后脂蛋白组成的这种变化在临床上也有观察到。